Trend — Not otherwise classified, antineoplastic drugs (J9999) in Medicare, the United States
Trend · J9999 · National · CY2024
Trend: Growing
Twelve-year services series · J9999 · the United Statesincluded in Explore
The full twelve-year services and payments series for this market — per-year values, with the FFS-enrollment denominator beside each.
Compound growth · endpointsincluded in Explore
The compound annual growth for J9999 in the United States — endpoints exclude the introduction year; an Exclude 2020–21 view drops the pandemic years too.